Showing results (381-390 of 566) with videos related to

Sort By:
Pageof 57
Arthritis & Rheumatology (Hoboken, N.J.)|December 5, 2018
Association of Dendritic Cell Signatures With Autoimmune Inflammation Revealed by Single-Cell ProfilingMichelle P Ashton, Anne Eugster, Sevina Dietz, et al.
Arthritis Care & Research|July 26, 2018
Time of Disease-Modifying Antirheumatic Drug Start in Juvenile Idiopathic Arthritis and the Likelihood of a Drug-Free Remission in Young AdulthoodKirsten Minden, Gerd Horneff, Martina Niewerth, et al.
The Lancet. Rheumatology|January 27, 2024
Long-term effect of tocilizumab in patients with giant cell arteritis: open-label extension phase of the Giant Cell Arteritis Actemra (GiACTA) trialJohn H Stone, Jian Han, Martin Aringer, et al.
The Journal of Rheumatology. Supplement|June 3, 2019
The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement SetYing Ying Leung, Ana-Maria Orbai, Alexis Ogdie, et al.
Arthritis and Rheumatism|August 29, 2009
Novel evidence-based systemic lupus erythematosus responder indexRichard A Furie, Michelle A Petri, Daniel J Wallace, et al.
Seminars in Arthritis and Rheumatism|August 3, 2022
Physicians' vs patients' global assessments of disease activity in rheumatology and musculoskeletal trials: A meta-research project with focus on reasons for discrepanciesChristian Lynæs, Maria Lynæs, Lee S Simon, et al.
The Journal of Rheumatology|November 3, 2005
Outcome measures in psoriatic arthritisDafna D Gladman, Philip J Mease, Gerald Krueger, et al.
Clinical and Experimental Rheumatology|July 15, 2020
ICHIBAN, a non-interventional study evaluating tocilizumab long-term effectiveness and safety in patients with active rheumatoid arthritisChristof Specker, Annette Alberding, Martin Aringer, et al.
Seminars in Arthritis and Rheumatism|June 2, 2022
Patient perspectives on long-term outcomes in rheumatoid arthritis. A qualitative study from the OMERACT patient outcomes in longitudinal studies working groupJosé B Negrón, Maria A Lopez-Olivo, Loreto Carmona, et al.
Rheumatology (Oxford, England)|April 2, 2013
Efficacy and safety of epratuzumab in patients with moderate/severe flaring systemic lupus erythematosus: results from two randomized, double-blind, placebo-controlled, multicentre studies (ALLEVIATE) and follow-upDaniel J Wallace, Caroline Gordon, Vibeke Strand, et al.
Pageof 57